[Glucose intolerance induced by tacrolimus (FK506), cyclosporin A].
Ueda
Kohei
K
Health Service Center, Organization for University Education, Yamaguchi University.
Tanizawa
Yukio
Y
D000328:Adult; D002118:Calcium / Q000378:metabolism; D036563:Cyclic ADP-Ribose / Q000502:physiology; D016572:Cyclosporine / Q000009:adverse effects*; D003926:Diabetic Coma / Q000139:chemically induced*; D018149:Glucose Intolerance / Q000139:chemically induced*; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D007328:Insulin / Q000235:genetics / Q000378:metabolism; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000187:drug effects / Q000378:metabolism; D008297:Male; D012333:RNA, Messenger / Q000235:genetics; D016559:Tacrolimus / Q000009:adverse effects*; D014158:Transcription, Genetic / Q000187:drug effects
D007166:Immunosuppressive Agents; D007328:Insulin; D012333:RNA, Messenger; D036563:Cyclic ADP-Ribose; D016572:Cyclosporine; D002118:Calcium; D016559:Tacrolimus